You are here

vaccines

GSK hands CureVac $294M to form mRNA infectious disease pact

GSK hands CureVac $294M to form mRNA infectious disease pact

Fierce Biotech

monoclonal antibodies

Flag link:

J&J to start human trials for COVID-19 vaccine this week

J&J to start human trials for COVID-19 vaccine this week

Beckers Hospital Review

clinical trials

Flag link:

Vaccine manufacturers testify before Congress

Vaccine manufacturers testify before Congress

Yahoo Finance

Flag link:

FDA guidance eases some Covid-19 vaccine concerns, but others remain

FDA guidance eases some Covid-19 vaccine concerns, but others remain

MedCity News

Flag link:

Which Biotech Company Has the Most Promising Coronavirus Vaccine?

Which Biotech Company Has the Most Promising Coronavirus Vaccine?

Motley Fool

Moderna Therapeutics

Flag link:

Medical researchers sign open letter calling for COVID-19 human challenge trials

Medical researchers sign open letter calling for COVID-19 human challenge trials

Beckers Hospital Review

clinical trials

Flag link:

Report: AstraZeneca's COVID-19 Vaccine Generates Antibodies and T-Cells Against the Virus in Phase I Trial

Report: AstraZeneca's COVID-19 Vaccine Generates Antibodies and T-Cells Against the Virus in Phase I Trial

BioSpace

University of Oxford

clinical trials

Flag link:

Is Moderna Close to Winning the Coronavirus Vaccine Race?

Is Moderna Close to Winning the Coronavirus Vaccine Race?

Motley Fool

Moderna Therapeutics

Flag link:

Abbott CEO: Covid-19 Testing Will Be Needed After A Vaccine’s Available

Abbott CEO: Covid-19 Testing Will Be Needed After A Vaccine’s Available

Forbes

Flag link:

Russian hackers feverishly working to steal COVID-19 vaccine research, governments say

Russian hackers feverishly working to steal COVID-19 vaccine research, governments say

Fierce Pharma

Flag link:

Why Is Moderna Already Making Coronavirus Vaccine Doses?

Why Is Moderna Already Making Coronavirus Vaccine Doses?

Motley Fool

Moderna Therapeutics

Flag link:

Head of Operation Warp Speed won't be forced to disclose investments in pharma companies

Head of Operation Warp Speed won't be forced to disclose investments in pharma companies

Beckers Hospital Review

Operation Warp Speed

conflict of interest

Flag link:

Full Results From Moderna's Coronavirus Vaccine Study Will Take 2 Years, at Least

Full Results From Moderna's Coronavirus Vaccine Study Will Take 2 Years, at Least

Motley Fool

Moderna Therapeutics

clinical trials

Flag link:

A day after Moderna vaccine results, rumors swirl of pending AstraZeneca data

A day after Moderna vaccine results, rumors swirl of pending AstraZeneca data

Endpoints

Moderna Therapeutics

Flag link:

NIAID and Moderna spell out a 'robust' immune response in PhI coronavirus vaccine test — but big questions remain to be answered

NIAID and Moderna spell out a 'robust' immune response in PhI coronavirus vaccine test — but big questions remain to be answered

Endpoints

Moderna Therapeutics

clinical trials

Flag link:

Merck KGaA's manufacturing group could see billions from COVID-19 work: analyst

Merck KGaA's manufacturing group could see billions from COVID-19 work: analyst

Fierce Pharma

drug manufacturing

Flag link:

Merck CEO Frazier says COVID-19 vaccine hype a 'grave disservice' to the public

Merck CEO Frazier says COVID-19 vaccine hype a 'grave disservice' to the public

Fierce Pharma

Flag link:

AstraZeneca taps IQVIA to 'warp speed' its U.S. pandemic vaccine research

AstraZeneca taps IQVIA to 'warp speed' its U.S. pandemic vaccine research

Fierce Biotech

Operation Warp Speed

Flag link:

Here's Why Inovio Is The Front-Runner In Developing a Coronavirus Vaccine

Here's Why Inovio Is The Front-Runner In Developing a Coronavirus Vaccine

Motley Fool

Flag link:

Are There Warning Signs About Moderna's COVID-19 Vaccine Program?

Are There Warning Signs About Moderna's COVID-19 Vaccine Program?

Motley Fool

Moderna Therapeutics

Flag link:

Pages